Liquid biopsy is a minimally invasive technique that analyzes circulating tumor cells (CTCs) or fragments of tumor DNA (ctDNA) in the bloodstream. This method provides real-time information about the genetic profile of the cancer, helping in the personalized treatment of patients. Liquid biopsies can be particularly useful for monitoring disease progression and detecting resistance to therapies.
